BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24503386)

  • 1. A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography.
    Hamada H; Matsuo A; Koizumi T; Satomi T; Chikazu D
    J Craniomaxillofac Surg; 2014 Sep; 42(6):924-9. PubMed ID: 24503386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerosis in bisphosphonate-related osteonecrosis of the jaws and its correlation with the clinical stages: study of 43 cases.
    Bagan JV; Cibrian RM; Lopez J; Leopoldo-Rodado M; Carbonell E; Bagán L; Utrilla J; Scully C
    Br J Oral Maxillofac Surg; 2015 Mar; 53(3):257-62. PubMed ID: 25560326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of digital subtraction technique to detect sclerotic changes in alveolar bone on intraoral radiographs of bisphosphonate-treated patients.
    Zaman MU; Nakamoto T; Tanimoto K
    Dentomaxillofac Radiol; 2013; 42(10):20130242. PubMed ID: 24404602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease.
    Bedogni A; Fedele S; Bedogni G; Scoletta M; Favia G; Colella G; Agrillo A; Bettini G; Di Fede O; Oteri G; Fusco V; Gabriele M; Ottolenghi L; Valsecchi S; Porter S; Petruzzi M; Arduino P; D'Amato S; Ungari C; Fung Polly PL; Saia G; Campisi G
    Br J Oral Maxillofac Surg; 2014 Sep; 52(7):603-8. PubMed ID: 24856927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
    López-Cedrún JL; Sanromán JF; García A; Peñarrocha M; Feijoo JF; Limeres J; Diz P
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):874-9. PubMed ID: 23866309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomographic assessment of early changes of the mandible in bisphosphonate-treated patients.
    Taniguchi T; Ariji Y; Nozawa M; Naitoh M; Kuroiwa Y; Kurita K; Ariji E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):362-72. PubMed ID: 27544397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate-related osteonecrosis of the jaw.
    Torres SR; Chen CS; Leroux BG; Lee PP; Hollender LG; Santos EC; Drew SP; Hung KC; Schubert MM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):695-703. PubMed ID: 22668629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
    Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
    Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
    Koth VS; Figueiredo MA; Salum FG; Cherubini K
    Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
    Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
    Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases.
    Bagan JV; Hens-Aumente E; Leopoldo-Rodado M; Poveda-Roda R; Bagan L
    Oral Oncol; 2012 Aug; 48(8):753-7. PubMed ID: 22401869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
    Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM
    J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.
    Hutchinson M; O'Ryan F; Chavez V; Lathon PV; Sanchez G; Hatcher DC; Indresano AT; Lo JC
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2232-40. PubMed ID: 20728032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
    Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
    Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
    Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.